MedPath

Comparison for Pethidine Requirement in Patients Received Spinal Morphine 0.2 and 0.3 mg for Post Lobectomy Analgesia

Phase 4
Completed
Conditions
Solitary Mass
Lung Diseases
Interventions
Drug: spinal morphine 0.2 mg
Drug: spinal morphine 0.3 mg
Registration Number
NCT01236495
Lead Sponsor
Mahidol University
Brief Summary

The purpose of the study is to evaluate the amount of total pethidine requirement during the 48 hour postoperative period after receiving spinal morphine 0.2 and 0.3 mg.

Detailed Description

Thoracotomy causes severe pain to the patients. Continuous thoracic epidural is a gold standard for postoperative pain. However, it needs skill. There are many alternatives such as spinal morphine, intercostal nerve block, cryoalangesia or interpleural block.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Age > 18 year and < 70 year
  • Patient ASA physical status I-III.
  • Scheduled for thoracotomy with lobectomy.
  • Can operate a patient-controlled analgesia (PCA) device.
Exclusion Criteria
  • Known hypersensitivity to morphine or pethidine
  • History of bleeding tendency.
  • Known case of infection at the back
  • Patient refuse for spinal anesthesia
  • History of cerebrovascular disease.
  • Scheduled for video-assisted thoracoscopic lobectomy.
  • Need mechanical ventilatory support during postoperative period

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
spinal morphine 0.2 mgspinal morphine 0.2 mgspinal morphine 0.2 mg
spinal morphine 0.3 mgspinal morphine 0.3 mgspinal morphine 0.3 mg
Primary Outcome Measures
NameTimeMethod
pethidine requirement48 hours

Total pethidine requirement during 48 hours postoperative

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of Medicine, Siriraj Hospital

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath